Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

被引:10
|
作者
Shkoda, Andrey S. [1 ]
Gushchin, Vladimir A. [2 ,3 ]
Ogarkova, Darya A. [2 ]
Stavitskaya, Svetlana, V [1 ]
Orlova, Olga E. [1 ]
Kuznetsova, Nadezhda A. [2 ]
Keruntu, Elena N. [1 ]
Pochtovyi, Andrei A. [2 ,3 ]
Pukhov, Alexander, V [1 ]
Kleymenov, Denis A. [2 ]
Krzhanovsky, Vasyli G. [1 ]
Vasina, Daria V. [2 ]
Shkuratova, Nataliya, V [1 ]
Shidlovskaya, Elena, V [2 ]
Gorbunov, Alexey L. [1 ]
Kustova, Daria D. [2 ,3 ]
Mazurina, Evgeniya A. [1 ]
Kozlova, Sofya R. [2 ]
Soboleva, Alexandra, V [1 ]
Grigoriev, Igor, V [2 ]
Pankratyeva, Lyudmila L. [1 ]
Odintsova, Alina S. [2 ]
Belyaeva, Elizaveta D. [2 ,3 ]
Bessonova, Arina A. [2 ]
Vasilchenko, Lyudmila A. [2 ]
Lupu, Igor P. [2 ]
Adgamov, Ruslan R. [2 ]
Tkachuk, Artem P. [2 ]
Tokarskaya, Elizaveta A. [2 ]
Logunov, Denis Y. [2 ]
Gintsburg, Alexander L. [2 ,4 ]
机构
[1] City Clin Hosp 67, Moscow City Dept, Moscow 123423, Russia
[2] Minist Hlth Russian Federat, Fed State Budget Inst, Natl Res Ctr Epidemiol & Microbiol, Moscow 123098, Russia
[3] Lomonosov Moscow State Univ, Biol Fac, Dept Virol, Moscow 119991, Russia
[4] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Minist Hlth Russian Federat, Dept Infectiol & Virol,Fed State Autonomous Educ, Moscow 119435, Russia
关键词
COVID-19; SARS-CoV-2; vaccine; Sputnik V; Sputnik Light; VOC; Omicron; vaccine effectiveness; VACCINE;
D O I
10.3390/vaccines10060938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing since the end of 2021. It is caused by a virus variant B.1.1.529, also known as "Omicron" and its descendants. The effectiveness of major vaccines against Omicron is not known. The purpose of this study is to evaluate the efficacy of the Sputnik V vaccine. The main goal is to assess its protection against hospitalization in the period of Omicron dominance. We conducted our study based on a large clinical center in Moscow (Russia) where 1112 patients were included. We used the case-population method to perform the calculations. The data we obtained indicate that the Omicron variant causes at least 90% of infections in the studied cohort. The effectiveness of protection against hospitalization with COVID-19 in our study was 85.9% (95% CI 83.0-88.0%) for those who received more than one dose. It was 87.6% (95% CI 85.4-89.5%) and 97.0% (95% CI 95.9-97.8%) for those who received more than two or three doses. The effectiveness in cases of more severe forms was higher than for less severe ones. Thus, present study indicates the high protective efficacy of vaccination against hospitalization with COVID-19 in case of Omicron lineage.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization
    Piche-Renaud, Pierre-Philippe
    Swayze, Sarah B.
    Buchan, Sarah
    Wilson, Sarah B.
    Austin, Peter Z.
    Morris, Shaun
    Nasreen, Sharifa E.
    Schwartz, Kevin M.
    Tadrous, Mina
    Thampi, Nisha H.
    Wilson, Kumanan E.
    Kwong, Jeffrey
    [J]. PEDIATRICS, 2023, 151 (04)
  • [2] Effectiveness of COVID-19 vaccines against Omicron variant
    de Oliveira Campos, Daniel Melo
    da Silva, Maria Karolaynne
    Silva de Oliveira, Claudio Bruno
    Fulco, Umberto Laino
    Nobre Oliveira, Jonas Ivan
    [J]. IMMUNOTHERAPY, 2022,
  • [3] Effectiveness of COVID-19 vaccines among children 6–11 years against hospitalization during Omicron predominance in Malaysia
    Vivek Jason Jayaraj
    Masliyana Husin
    Jing Lian Suah
    Peter Seah Keng Tok
    Azahadi Omar
    Sanjay Rampal
    Sheamini Sivasampu
    [J]. Scientific Reports, 14
  • [4] SAFETY AND EFFECTIVENESS OF COVID-19 SPUTNIK V VACCINE IN DIALYSIS PATIENTS
    Rosa-Diez, Guillermo
    Leiva, Maria Marina Papaginovic
    Lombi, Fernando
    Crucelegui, Maria Soledad
    Martinez, Ricardo D.
    Trimarchi, Hernan
    Schiavelli, Ruben
    Grizzo, Mercedes
    Rano, Miguel
    Heguilen, Ricardo M.
    Jones, Rocio A.
    Paganti, Luciana Gonzalez
    Ferrrari, Matias
    Kjohede, Victoria
    Zingoni, Paula
    Geffner, Jorge R.
    Ferrante, Daniel
    De Quiros, Fernan Gonzalez Bernaldo
    Pagotto, Vanina
    [J]. MEDICINA-BUENOS AIRES, 2022, 82 (05) : 631 - 640
  • [5] Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
    Sukhikh, Gennady T.
    Priputnevich, Tatiana, V
    Ogarkova, Darya A.
    Pochtovyi, Andrei A.
    Kustova, Daria D.
    Zlobin, Vladimir, I
    Logunov, Denis Y.
    Gushchin, Vladimir A.
    Gintsburg, Alexander L.
    [J]. VACCINES, 2022, 10 (11)
  • [6] Effectiveness of COVID-19 vaccines among children 6-11 years against hospitalization during Omicron predominance in Malaysia
    Jayaraj, Vivek Jason
    Husin, Masliyana
    Suah, Jing Lian
    Tok, Peter Seah Keng
    Omar, Azahadi
    Rampal, Sanjay
    Sivasampu, Sheamini
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [7] Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
    Accorsi, Emma K.
    Britton, Amadea
    Shang, Nong
    Fleming-Dutra, Katherine E.
    Link-Gelles, Ruth
    Smith, Zachary R.
    Derado, Gordana
    Miller, Joseph
    Schrag, Stephanie J.
    Verani, Jennifer R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (25): : 2433 - 2435
  • [8] Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks
    Albreiki, Mohammed
    Mousa, Mira
    Azman, Syafiq Kamarul
    Vurivi, Hema
    Alhalwachi, Zainab
    Alshehhi, Fatima
    AlShamsi, Safiya
    Marzouqi, Nada Al
    Alawadi, Tayba
    Alrand, Hussain
    Oulhaj, Abderrahim
    Fikri, Asma
    Alsafar, Habiba
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] The Sputnik V Vaccine against COVID-19: A Promising Platform for Mass Vaccination
    Israeli, Eitan
    Shoenfeld, Yehuda
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (02): : 71 - 73
  • [10] Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
    Higdon, Melissa M.
    Baidya, Anurima
    Walter, Karoline K.
    Patel, Minal K.
    Issa, Hanane
    Espie, Emmanuelle
    Feikin, Daniel R.
    Knoll, Maria Deloria
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (08): : 1114 - 1116